SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

Reviva Pharmaceuticals Holdings Sees Net Operating Loss For 3 Months Ended March 31, 2021 Is Expected To Be ~$1.9M

-Reuters

05/10/2021 09:39